Bioactive Wound Management - Global Market Trajectory & Analytics

Description Table of
Contents

LOGIN TO ACCESS EXECUTIVE SUMMARY
PRINTER FRIENDLY

Global Bioactive Wound Management Market to Reach $2.8 Billion by 2027

Amid the COVID-19 crisis, the global market for Bioactive Wound Management estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$2.8 Billion by 2027, growing at a CAGR of 11.2% over the analysis period 2020-2027. Xenografts, one of the segments analyzed in the report, is projected to record a 11.7% CAGR and reach US$554.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Allografts segment is readjusted to a revised 12.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $395.4 Million, While China is Forecast to Grow at 10.7% CAGR

The Bioactive Wound Management market in the U.S. is estimated at US$395.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$492 Million by the year 2027 trailing a CAGR of 10.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.8% and 9.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Bioengineered Skin Substitutes Segment to Record 11% CAGR

In the global Bioengineered Skin Substitutes segment, USA, Canada, Japan, China and Europe will drive the 10.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$194.4 Million in the year 2020 will reach a projected size of US$398.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$330.5 Million by the year 2027.

Select Competitors (Total 44 Featured):

3M Company
Acelity LP, Inc.
ACell Inc.
Convatec Group PLC
Covalon Technologies Ltd.
Integra LifeSciences Holdings Corporation
MiMedx Group, Inc.
Smith & Nephew PLC
SYMATESE
Wright Medical Group NV

Note: Product cover images may vary from those shown

LOGIN TO ACCESS EXECUTIVE SUMMARY
PRINTER FRIENDLY

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Current & Future Analysis for Bioactive Wound Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 2: World 7-Year Perspective for Bioactive Wound Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
Table 3: World Current & Future Analysis for Xenografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 4: World 7-Year Perspective for Xenografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 5: World Current & Future Analysis for Allografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 6: World 7-Year Perspective for Allografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 7: World Current & Future Analysis for Bioengineered Skin Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 8: World 7-Year Perspective for Bioengineered Skin Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 9: World Current & Future Analysis for Collagen-based Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 10: World 7-Year Perspective for Collagen-based Dressings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 11: World Current & Future Analysis for Topical Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 12: World 7-Year Perspective for Topical Dressings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 13: World Current & Future Analysis for Venous Leg Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 14: World 7-Year Perspective for Venous Leg Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 15: World Current & Future Analysis for Diabetic Foot Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 16: World 7-Year Perspective for Diabetic Foot Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 17: World Current & Future Analysis for Pressure Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 18: World 7-Year Perspective for Pressure Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 19: World Current & Future Analysis for Surgical Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 20: World 7-Year Perspective for Surgical Wounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
Table 21: World Current & Future Analysis for Burn Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 22: World 7-Year Perspective for Burn Wounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 23: USA Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 24: USA 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
Table 25: USA Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 26: USA 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
CANADA
Table 27: Canada Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 28: Canada 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
Table 29: Canada Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 30: Canada 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
JAPAN
Table 31: Japan Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 32: Japan 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
Table 33: Japan Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 34: Japan 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
CHINA
Table 35: China Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 36: China 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
Table 37: China Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 38: China 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
EUROPE
Table 39: Europe Current & Future Analysis for Bioactive Wound Management by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 40: Europe 7-Year Perspective for Bioactive Wound Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Table 41: Europe Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 42: Europe 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
Table 43: Europe Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 44: Europe 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
FRANCE
Table 45: France Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 46: France 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
Table 47: France Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 48: France 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
GERMANY
Table 49: Germany Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 50: Germany 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
Table 51: Germany Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 52: Germany 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
ITALY
Table 53: Italy Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 54: Italy 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
Table 55: Italy Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 56: Italy 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
UNITED KINGDOM
Table 57: UK Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 58: UK 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
Table 59: UK Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 60: UK 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
REST OF EUROPE
Table 61: Rest of Europe Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 62: Rest of Europe 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
Table 63: Rest of Europe Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 64: Rest of Europe 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
ASIA-PACIFIC
Table 65: Asia-Pacific Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 66: Asia-Pacific 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
Table 67: Asia-Pacific Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 68: Asia-Pacific 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027
REST OF WORLD
Table 69: Rest of World Current & Future Analysis for Bioactive Wound Management by Product - Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 70: Rest of World 7-Year Perspective for Bioactive Wound Management by Product - Percentage Breakdown of Value Sales for Xenografts, Allografts, Bioengineered Skin Substitutes, Collagen-based Dressings and Topical Dressings for the Years 2020 & 2027
Table 71: Rest of World Current & Future Analysis for Bioactive Wound Management by Application - Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 72: Rest of World 7-Year Perspective for Bioactive Wound Management by Application - Percentage Breakdown of Value Sales for Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds and Burn Wounds for the Years 2020 & 2027

IV. COMPETITION

Total Companies Profiled: 44

Note: Product cover images may vary from those shown

RELATED TAGS

RELATED PRODUCTS

Bioactive Wound Dressing Market - Growth, Trends, and Forecasts (2020 - 2025)

Traditional Wound Management Products - Global Market Trajectory & Analytics

Bioactive Wound Care Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type

Global Wound Management Devices Market By Product, By Application, By End User, By Region, Industry Analysis and Forecast, 2020 - 2026

Bioactive Wound Care Market Research Report by Product Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19